Cellnovo Group (“Cellnovo” CLNV:EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system today announces that delivery of the first batch of its Insulin cartridges produced by Flex (Flextronics), has been received. The delivery of this first batch of cartridges demonstrates that the automated manufacturing solution developed by Flex is complete.
The cartridge assembly includes high precision molded parts, now produced in a medical device clean-room facility at Flex, which marks the completion of a significant investment programme in new tooling for long term mass production.
Flex and Cellnovo are now focused on documentation and testing building up to full scale manufacturing, which remains on track and targeted for the second half of 2016.